Mount Sinai Saint Luke's — New York, New York

Mount Sinai Saint Luke's is a clinical research site located in New York, New York, United States 10025.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai Saint Luke's has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Saint Luke's?

Mount Sinai Saint Luke's has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Saint Luke's conducted?

Mount Sinai Saint Luke's has 1 clinical trials on record. Their work covers Metastatic Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7.

Is Mount Sinai Saint Luke's accredited by Crixeo Health?

Mount Sinai Saint Luke's has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Saint Luke's?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.